1. Home
  2. PT vs LEXX Comparison

PT vs LEXX Comparison

Compare PT & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pintec Technology Holdings Limited

PT

Pintec Technology Holdings Limited

HOLD

Current Price

$1.01

Market Cap

14.7M

Sector

Technology

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.69

Market Cap

16.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PT
LEXX
Founded
2012
2004
Country
China
Canada
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.7M
16.3M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
PT
LEXX
Price
$1.01
$0.69
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
68.2K
1.5M
Earning Date
09-19-2025
01-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,961,892.00
$705,923.00
Revenue This Year
N/A
$13.35
Revenue Next Year
N/A
$78.83
P/E Ratio
N/A
N/A
Revenue Growth
9.20
52.05
52 Week Low
$0.76
$0.46
52 Week High
$1.38
$2.43

Technical Indicators

Market Signals
Indicator
PT
LEXX
Relative Strength Index (RSI) 58.23 43.39
Support Level $0.92 $0.46
Resistance Level $0.99 $0.72
Average True Range (ATR) 0.05 0.10
MACD 0.01 0.01
Stochastic Oscillator 80.00 58.20

Price Performance

Historical Comparison
PT
LEXX

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: